🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 44% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

6 Gram(s) Serving Size
30 Servings
Other Combinations Product Type
44% Evidence Coverage

Supplement Facts — Evidence Check

Calories
5 Calorie(s)
Total Carbohydrates
1 Gram(s) (1% DV)
17 mg (85% DV)
✅ 1.2× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 17mg UL 35mg
8 mg (400% DV)
📊 6.2× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 8mg UL 100mg
10 mcg (168% DV)
📊 4.2× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.01mg
33 mg (8% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 33mg
Sodium
110 mg (5% DV)
Potassium
230 mg (7% DV)
Proprietary Lipobolic Blend
2137 mg

Other Ingredients

Maltodextrin Citric Acid Natural & Artificial Flavors Silicon Dioxide Malic Acid Sucralose Acesulfame Potassium FD&C Yellow #5

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Directions: Mix one (1) scoop with 8-12 oz. of cold water 20-30 minutes before training. Begin with one (1) scoop to assess your tolerance. Increase servings to no more than (2) two scoops per day for desired effect. This is a stimulant based supplement, always check with a physician or health care provider prior to taking supplements and exercising.

⚠️ Warnings & Precautions

Warning: Not intended for use by persons under age 18.

Do not exceed recommended dose. Do not consume synephrine or caffeine from other sources, including but not limited to: coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine. Contains caffeine. Do not use for more than 8 weeks. Discontinue 2 weeks prior to surgery or if you experience rapid heartbeat, dizziness, severe headache or shortness or breath.

Do not use if you are pregnant, nursing or contemplating becoming pregnant. Consult with your physician prior to use if you are taking medication, including but not limited to: MAO inhibitors, antidepressants, aspirin, nonsteroidal anti-inflammatory drugs or products containing phylephrine, ephedrine, pseudoephedrine, or other stimulants. Consult your physician prior to use if you have a medical condition, including but not limited to: heart, liver, kidney, or thyroid disease, psychiatric or epileptic disorders, difficulty urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma.

🧪 Formulation Notes

Aerobic capacity booster Performance enhancing diet aid Improved endurance Cardio Igniter is a new type of pre-workout, performance-enhancing supplement that focuses on supporting aerobic capacity and losing weight. Use Cardio Igniter to protect lean muscle mass, support weight loss, and provide long lasting energy.

Professional grade performance enhancer

Cardio Igniter Pineapple Mango Naturally & artificially flavored

Additional Information

Store in a cool, dry place.

Product Details

UPC / SKU 8 11226 02185 0
DSLD Entry Date 2025-01-23
Product Type Other Combinations
Form Powder
DSLD ID 323446
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →